Providing Supplemental Protection with PCV20/21
Why Vaccination Tracking Matters:
Keeping track of vaccinations is an important element of keeping our high-risk population safe from the complications of infection. Best practices of a strong nursing home infection prevention and control program include reviewing immunization history on admission and routinely throughout a nursing home stay. Nursing home providers and staff should be prepared to provide education to residents and their families about vaccine eligibility, in alignment with CDC recommendations.
Probari Quality Review Process:
Part of the Probari Quality Review process includes evaluating a resident’s pneumococcal vaccination status and communicating potential vaccination needs identified during the review. According to CDC guidance, for some older adults who previously received pneumococcal vaccines, it may be appropriate to offer supplemental vaccination to broaden their protection against pneumococcal infections.
Supplemental Pneumococcal Vaccination Guidance:
For higher-risk adults 65 or older with a chronic condition who live in a nursing home, supplemental vaccination with PCV20 or PCV21 after they have previously received PCV13 and PPSV23 may be appropriate and should be discussed with them and their healthcare provider. The dose of either PCV20 or PCV21 may be given 5 years after previous PCV13 or PPSV23 vaccination.
CDC Decision Support Resources:
We have included links from the CDC to determine which residents may be appropriate for this supplemental pneumococcal vaccine via the PneumoRecs VaxAdvisor, and a CDC guide that can support this shared-clinical decision-making conversation.
Resources:
Shared Clinical Decision-Making: PCV20 Vaccination for Adults 65 Years or Older
